AAAAAA
Results:
1-13
|
Results: 13
Authors:
Flugel, A
Matsumuro, K
Neumann, H
Klinkert, WEF
Birnbacher, R
Lassmann, H
Otten, U
Wekerle, H
Citation: A. Flugel et al., Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration, EUR J IMMUN, 31(1), 2001, pp. 11-22
Authors:
Hock, C
Heese, K
Muller-Spahn, F
Huber, P
Riesen, W
Nitsch, RM
Otten, U
Citation: C. Hock et al., Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression, MOL PSYCHI, 5(5), 2000, pp. 510-513
Authors:
Moalem, G
Gdalyahu, A
Shani, Y
Otten, U
Lazarovici, P
Cohen, IR
Schwartz, M
Citation: G. Moalem et al., Production of neurotrophins by activated T cells: Implications for neuroprotective autoimmunity, J AUTOIMMUN, 15(3), 2000, pp. 331-345
Authors:
Hock, C
Heese, K
Olivieri, G
Hulette, C
Rosenberg, C
Nitsch, RM
Otten, U
Citation: C. Hock et al., Alterations in neurotrophins and neurotrophin receptors in Alzheimer's disease, J NEUR TR-S, (59), 2000, pp. 171-174
Authors:
Heese, K
Otten, U
Mathivet, P
Raiteri, M
Marescaux, C
Bernasconi, R
Citation: K. Heese et al., GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats, NEUROPHARM, 39(3), 2000, pp. 449-462
Authors:
Hock, C
Heese, K
Muller-Spahn, F
Huber, P
Riesen, W
Nitsch, RM
Otten, U
Citation: C. Hock et al., Increased CSF levels of nerve growth factor in patients with Alzheimer's disease, NEUROLOGY, 54(10), 2000, pp. 2009-2011
Authors:
Savaskan, E
Muller-Spahn, F
Olivieri, G
Bruttel, S
Otten, U
Rosenberg, C
Hulette, C
Hock, C
Citation: E. Savaskan et al., Alterations in TrkA, TrkB and TrkC receptor immunoreactivities in parietalcortex and cerebellum in Alzheimer's disease, EUR NEUROL, 44(3), 2000, pp. 172-180
Authors:
Grothe, C
Heese, K
Meisinger, C
Wewetzer, K
Kunz, D
Cattini, P
Otten, U
Citation: C. Grothe et al., Expression of interleukin-6 and its receptor in the sciatic nerve and cultured Schwann cells: relation to 18-kD fibroblast growth factor-2, BRAIN RES, 885(2), 2000, pp. 172-181
Authors:
Hock, C
Heese, K
Hulette, C
Rosenberg, C
Otten, U
Citation: C. Hock et al., Region-specific neurotrophin imbalances in Alzheimer disease Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas, ARCH NEUROL, 57(6), 2000, pp. 846-851
Authors:
Marz, P
Otten, U
Rose-John, S
Citation: P. Marz et al., Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors, EUR J NEURO, 11(9), 1999, pp. 2995-3004
Authors:
Marz, P
Heese, K
Dimitriades-Schmutz, B
Rose-John, S
Otten, U
Citation: P. Marz et al., Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression, GLIA, 26(3), 1999, pp. 191-200
Authors:
Thier, M
Marz, P
Otten, U
Weis, J
Rose-John, S
Citation: M. Thier et al., Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons, J NEUROSC R, 55(4), 1999, pp. 411-422
Authors:
Roskoden, T
Heese, K
Otten, U
Schwegler, H
Citation: T. Roskoden et al., Modulation of mRNA expression of the neurotrophins of the nerve-growth-factor family and their receptors in the septum and hippocampus of rats after transient postnatal thyroxine treatment. II. Effects on p75 and trk receptor expression, EXP BRAIN R, 127(3), 1999, pp. 307-313
Risultati:
1-13
|